Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Psychiatry/Psychology | Family Medicine
Generalized Anxiety Disorder (GAD) Clinical Trials
A listing of Generalized Anxiety Disorder (GAD) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Birmingham Research Group, Inc
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
California
Encino : Pharmacology Research Institute, Encino
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients with Generalized Anxiety Disorder
Newport Beach : Pharmacology Research Institute, Newport Beach
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients with Generalized Anxiety Disorder
View More »
Carson : Dr. Joseph H. Rodd
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Imperial : Sun Valley Research
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Irvine : Irvine Center for Clinical Research
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
San Diego : Sharp Mesa Vista Hospital, Clinical Research Department
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Wildomar : Elite Clinical Trials, Inc
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Florida
Bradenton : Florida Clinical Research Center
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Gainsville : Sarkis Clinical Trials
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Winter Park : Kolin Research Group
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Georgia
Smyrna : Institute of Behavioral Medicine, LLC
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Louisiana
Lake Charles : Lake Charles Clinical Trials
Evaluating the efficacy and safety of vilazodone compared to placebo in the treatment of adults with generalized anxiety disorder (GAD)
View More »
Lake Charles : Lake Charles Clinical Trials
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Michigan
Rochester Hills : Rochester Center for Behavioral Medicine
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Missouri
St Charles : Midwest Research Group
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Nebraska
Lincoln : Premier Psychiatric Group, LLC
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Nevada
Las Vegas : Center for Psychiatry and Behavioral Medicine, Inc
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
New Jersey
Cherry Hill : Center for Emotional Fitness
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
New York
Rochester : Finger Lakes Clinical Research
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Staten Island : Richmond Behavioral Associates
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
North Carolina
Durham : Duke University Medical Center, Duke Child and Family Study Center
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Ohio
Cincinnati : University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Cleveland : University Hospitals of Cleveland Medical Center
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Middleburg Heights : North Star Research
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Oklahoma
Oklahoma City : IPS Research Company
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Rhode Island
Tennessee
Memphis : Research Strategies of Memphis, LLC
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Texas
Austin : FutureSearch Clinical Trials, LP
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Houston : Houston Clinical Trials LLC
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Utah
Salt Lake City : CRI Lifetree
To evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo
in the treatment of generalized anxiety disorder (GAD).
View More »
Clinton : Ericksen Research and Development
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Virginia
Charlottesville : Charlottesville Medical Research
Do you suffer from Generalized Anxiety Disorder (GAD)?
View More »
Herndon : NeuroScience, Inc.
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
